Information  X 
Enter a valid email address

UDG Healthcare Plc (UDG)

  Print      Mail a friend       Annual reports

Tuesday 30 July, 2019

UDG Healthcare Plc

Notice of Q3 2019 Trading Update

RNS Number : 0858H
UDG Healthcare Public Limited Co.
30 July 2019




UDG Healthcare plc


Notice of Q3 2019 Trading Update


30 July 2019: UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading international healthcare services provider, will issue a trading update for the third quarter to 30 June 2019 at 7.00a.m. (BST) on Wednesday, 7 August 2019.


The Company will also host a conference call for investors and analysts at 8.00am (BST) on Wednesday, 7 August 2019 to discuss the statement. The dial-in details are as follows:


Standard International Access

+44 (0) 20 3037 9299

UK Toll Free

0800 368 2555

Ireland Toll Free

1 800 930 488

Ireland local

+353 (0) 1 436 0959


UDG Healthcare


A playback facility will be available for seven days on +44 (0) 203 451 9993. The access code for the replay will be 9471508#.


For further information, please contact:


Keith Byrne

Head of Investor Relations, Strategy & Corporate Communications

UDG Healthcare plc

Tel: +353-1-468-9000


Lisa Kavanagh / Jack Hickey / Ella Morris


Tel: +44-207-250-1446

Email: [email protected]



About UDG Healthcare plc:


UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 9,000 people with operations in 26 countries and delivering services in over 50 countries.


UDG Healthcare plc operates across two divisions: Ashfield and Sharp.


Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.


Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.


The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to:

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t